Trimurthi Drugs & Pharmaceuticals Limited reported unaudited earnings results for the third quarter and nine months ended December 31, 2011. For the quarter, the company reported total income of INR 46.657 million compared to INR 53.775 million a year ago. Profit from ordinary activities before tax was INR 2.205 million compared to INR 1.868 million a year ago. Net profit was INR 1.675 million or INR 0.25 per basic and diluted share before extraordinary items compared to INR 1.868 million or INR 0.28 per basic and diluted share before extraordinary items a year ago. For the nine months, the company reported total income of INR 95.365 million compared to INR 135.193 million a year ago. Profit from ordinary activities before tax was INR 5.633 million compared to INR 4.423 million a year ago. Net profit was INR 4.118 million or INR 0.61 per basic and diluted share before extraordinary items compared to INR 4.423 million or INR 0.66 per basic and diluted share before extraordinary items a year ago.